Skip to main content

Protagenic Therapeutics, Inc. (PTIX)

NASDAQ: PTIX · IEX Real-Time Price · USD
1.63
-0.09 (-5.23%)
At close: Dec 3, 2021 4:00 PM
1.68
0.05 (3.07%)
After-hours:Dec 3, 2021 7:59 PM EST
Market Cap27.64M
Revenue (ttm)n/a
Net Income (ttm)-4.16M
Shares Out16.96M
EPS (ttm)-0.32
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume72,232
Open1.70
Previous Close1.72
Day's Range1.63 - 3.71
52-Week Range1.55 - 4.89
Beta-0.46
Analystsn/a
Price Targetn/a
Earnings DateNov 15, 2021

About PTIX

Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.

IndustryBiotechnology
IPO DateJan 5, 2016
Employees1
Stock ExchangeNASDAQ
Ticker SymbolPTIX
Full Company Profile

Financial Performance

Financial Statements

News

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today a...

2 weeks ago - GlobeNewsWire

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and A ddiction to be discussed

3 months ago - GlobeNewsWire

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today a...

3 months ago - GlobeNewsWire

Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End

Upon reviewing Protagenic Therapeutics Inc's (NASDAQ: PTIX) Investigational New Drug (IND) application for its lead compound, PT00114, the FDA has currently rejected the Company's IND. The application s...

4 months ago - Benzinga

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today a...

4 months ago - GlobeNewsWire

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at...

NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today a...

4 months ago - GlobeNewsWire

7 Best Penny Stocks to Buy Now for Potential 10X Gains

Penny stocks offer a lot of risk balanced by lots of reward. Here are 7 that could surge in price and which have reasonable catalysts behind them.

5 months ago - InvestorPlace

Penny Stocks to Watch With AMC Stock Back in Focus

In a recent pennystocks.com article, we covered 5 Penny Stocks on Reddit for Your June 2021 Watchlist. This piece is a continuation, as more and more valuable penny stocks continue to come to light. Rig...

Other symbols:BOXLCFMSCLSDUXIN
5 months ago - PennyStocks

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on...

NEW YORK , June 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a bioharmaceutical company focused on developing drug product candidates to treat stress-related neurologic diso...

5 months ago - GlobeNewsWire

Best Biotech Penny Stocks in June 2021? Check These 4 Out

Looking for biotech penny stocks for your June watchlist? Here's 4 to watch The post Best Biotech Penny Stocks in June 2021?

Other symbols:PIRSSESNTTOO
6 months ago - PennyStocks

4 Biotech Penny Stocks That You Need to Know About

These biotech penny stocks pushed up big today; but are they worth it? The post 4 Biotech Penny Stocks That You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other symbols:IBIOPRPO
6 months ago - PennyStocks

Market Update: The 10 Most Volatile Stocks Today

Joins us as we take a look at the most volatile stocks for Monday as many shares see their prices fluctuate during the day. The post Market Update: The 10 Most Volatile Stocks Today appeared first on In...

6 months ago - InvestorPlace

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

New York, April 29, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the closing of an underwritten public offering of 3,180,000 units at a publ...

7 months ago - GlobeNewsWire

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

New York, April 26, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the pricing of an underwritten public offering of 3,180,000 units at a publ...

7 months ago - GlobeNewsWire